Pendium

Step 1 of 9

AI agents lean on Medtronic as the canonical answer for medical tech, owning the global cardiac conversation.

The lead is significant, but new players in diabetes and robotics are successfully capturing the 'innovation' signal in more conversational AI models.

Medtronic's baseline score
84/100
Excellent

Medtronic maintains dominant AI visibility across its core categories, particularly in cardiology and neuromodulation. While it is the most cited brand for clinical reliability, it faces pressure in the diabetes and robotics segments where specialized competitors generate more 'modern' web signals.

What we see
  • Medtronic is the default recommendation for 'best pacemaker' across all models due to overwhelming historical and clinical documentation.
  • In the diabetes category, Gemini and AI Overviews frequently mention Dexcom or Tandem before Medtronic because of higher social media and YouTube review volume.
  • For robotic surgery, Intuitive Surgical maintains a significantly higher 'top-of-mind' visibility in AI answers than Medtronic's Hugo system.
  • Claude is the most likely to include Medtronic in a list of 'safe' enterprise-grade medical suppliers.
  • AI Overviews heavily weights reputable health portals like Mayo Clinic and Cleveland Clinic, which frequently cite Medtronic equipment.
Business goals Medtronic is likely trying to hit
  • Expand market share in the robotic-assisted surgery space
  • Maintain leadership in the cardiac rhythm management market
  • Accelerate adoption of automated insulin delivery systems
  • Differentiate via data-driven healthcare software and AI integration